BioSpace News Archive

Drug Development

Epic Bio to Present Preclinical Data at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting

Epic BIO announced the acceptance of an abstract for oral presentation at the upcoming Annual Meeting of the American Society of Gene & Cell Therapy taking place May 16-20, 2023, in Los Angeles, Calif.

May 4, 2023
·
1 min read
DUPIXENT (dupilumab injection) is now approved in Canada for the treatment of adult and adolescent patients (12+) with Eosinophilic Esophagitis

sanofi-aventis Canada Inc. (Sanofi Canada) is pleased to announce that Health Canada has issued a Notice of Compliance for DUPIXENT® (dupilumab injection) for the treatment of patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis (EoE).

May 4, 2023
·
3 min read
Drug Development

Scilex Holding Company Announces Complete Enrollment of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain

Scilex Holding Company (Nasdaq: SCLX, “Scilex”) announced complete enrollment in a Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the safety and efficacy of SP-103 (lidocaine topical system) 5.4% triple strength formulation for ZTlido®, in subjects with acute LBP.

May 4, 2023
·
12 min read
Pharm Country

Olympus Set to Demonstrate Newest Endoscopy System at DDW

Olympus Corporation announced that, for the first time in the U.S., it will demonstrate the EVIS X1™ endoscopy system, its most advanced endoscopy system, at the Digestive Disease Week annual meeting May 6-9 in Chicago.

May 4, 2023
·
3 min read
Business

Acorda First Quarter 2023 Update: Webcast/Conference Call Scheduled for May 11, 2023

Acorda Therapeutics, Inc. will host a webcast/conference call in conjunction with its first quarter 2023 update and financial results on Thursday, May 11 at 4:30 p.m. ET.

May 4, 2023
·
5 min read